Patent Assignment
Reel/Frame 039136/0563
Assignment of Assignor's Interest
Recorded: 2016-07-12
Pages: 6
Assignee
4-ANTIBODY AG
HOCHBERGERSTRASSE 60C, BASEL, CH-4057, SWITZERLAND
Covered Property
(1)
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Patent:
10,144,779 →
Application:
15/166,305 →
Publication:
US 2016/0368989
PCT:
PCT/US2016/034508 ↗
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 12, 2016
From: RITTER, GERD
To: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Reel/Frame 039136/0576 →
Assignment of Assignor's Interest
Jul 12, 2016
From: WILSON, NICHOLAS STUART; SAVITSKY, DAVID ADAM; FINDEIS, MARK ARTHUR
To: AGENUS INC.
Reel/Frame 039136/0516 →
Assignment of Assignor's Interest
Jul 12, 2016
From: 4-ANTIBODY AG
To: AGENUS INC.
Reel/Frame 039136/0571 →
Assignment of Assignor's Interest
Jul 18, 2016
From: WOLCHOK, JEDD DAVID; MERGHOUB, TAHA; SCHAER, DAVID
To: MEMORIAL SLOAN KETTERING CANCER CENTER
Reel/Frame 039174/0467 →
Security Interest
Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Amended and Restated Patent Security Agreement
Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Security Interest
Mar 31, 2025
From: AGENUS, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 070680/0634 →